Abstract:This study reports a novel macrophage‐derived extracellular vesicle‐coated palladium (Pd@M) nanoformulation for the targeted treatment of ulcerative colitis (UC). Pd@M can potently scavenge ROS, remodel the colonic inflammatory and immune microenvironments in vivo, and ultimately improve mucosal barrier function and induce the remission of UC, providing a promising alternative option for clinical application. Ulcerative colitis (UC) is a chronic inflammatory bowel disease mainly involving the colon and rectum, which features recurrent mucosal inflammation. The excessive production of reactive oxygen species (ROS) is a trigger for pathological changes such as cell apoptosis and disordered immune microenvironments, which are crucial for the progression of UC and can be a promising therapeutic target. Nowadays, the development of targeted therapeutic strategies for UC is still in its infancy. Thus, developing effective therapies based on ROS scavenging and elucidating their molecular pathways are urgently needed. Herein, a biomimetic nanoformulation (Pd@M) with cubic palladium (Pd) as the core and macrophage‐derived extracellular vesicles (MEVs) as the shell is synthesized for the treatment of UC. These Pd@M nanoformulations exhibit multienzyme‐like activities for effective ROS scavenging, excellent targeting ability as well as good biocompatibility. It is verified that Pd@M can regulate the polarization state of macrophages by inhibiting glycolysis, and decrease neutrophil infiltration and recruitment. In this way, the colonic inflammatory and immune microenvironment is remodeled, and apoptosis is prevented, ultimately improving colonic mucosal barrier function and alleviating colitis in the mouse model. This finding provides a promising alternative option for the treatment of UC patients.

Macrophage-based Nanotherapeutic Strategies in Ulcerative Colitis.

Advances in Macrophage-Targeting Nanoparticles for the Diagnosis and Treatment of Inflammatory Bowel Disease.

A potential therapeutic approach for ulcerative colitis: targeted regulation of macrophage polarization through phytochemicals

Colon-targeted piperine-glycyrrhizic acid nanocrystals for ulcerative colitis synergetic therapy via macrophage polarization

Advancements of Macrophages Involvement in Pathological Progression of Colitis-Associated Colorectal Cancer and Associated Pharmacological Interventions

Mechanism of Nrf2 in the treatment of ulcerative colitis via regulating macrophage polarization.

Strategies and opportunities of micro/nano delivery systems for targeted therapy of ulcerative colitis: Focus on underlying mechanisms and future perspectives

Roles of macrophages on ulcerative colitis and colitis-associated colorectal cancer

Macrophage‐Derived Extracellular Vesicles‐Coated Palladium Nanoformulations Modulate Inflammatory and Immune Homeostasis for Targeting Therapy of Ulcerative Colitis

Intestinal Macrophage Autophagy and its Pharmacological Application in Inflammatory Bowel Disease

A potential therapeutic target in traditional Chinese medicine for ulcerative colitis: Macrophage polarization

Cross-talk between macrophages and gut microbiota in inflammatory bowel disease: a dynamic interplay influencing pathogenesis and therapy

Ulcerative colitis: molecular insights and intervention therapy

An ROS/DAMP dual-scavenging nanomedicine for normalizing macrophage polarization and microbiome in colitis

Estimation of thermal constants: the importance of using equilibrium temperature rather than ambient temperature demonstrated with hoverflies (Diptera, Syrphidae, genus Eristalis).

Advances in natural compound-based nanomedicine and the interaction with gut microbiota in ulcerative colitis therapy

Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD

Macrophage polarization: an effective approach to targeted therapy of inflammatory bowel disease

Dual‐Targeted Nanoparticle‐In‐Microparticle System for Ulcerative Colitis Therapy

Macrophage-Biomimetic Nanoparticles Ameliorate Ulcerative Colitis through Reducing Inflammatory Factors Expression